| wdt_ID | id | Title | subtitleacronyms | protocolnumber | versionnumber | phaseofstudy | studytype | nameofapplicant | addressofapplicant | applicationdate | nameofsponsor | addressofsponsor | trialsites | producttype | Application Status | trialauthorisationdate | statusofapprovedtrials | details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | A Multicentre, Double blind, Randomized, parallel group, clinical trial to compare the sexual pleasure, performance, acceptability and safety of Graphene incorporated natural rubber latex condoms and natural rubber latex compounds in healthy humans. | Graphene condom study | ECTS/17/001/EC10018 | Version 02 | Phase 3; | industry sponsor | Xcene Research Ltd | 15, Ogulana Street, off Allen Avennue, Ikeja, Lagos | 11/02/2019 | The George Institute for Global Health, | Level 10, King George V Building, 83-117 Missenden Road, Camperdown WSW 2050. | 1. University of Ilorin Teaching Hospital (UITH), Ilorin. 2. Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, 3. Lagos University Teaching Hospital (LUTH), Lagos 4. Jos University Teaching Hospital (JUTH), Jos 5. University College Hospital (UCH) | Medical Device | Approved | 26/09/2019 | Recruiting | ?id=1 |
| 2 | 4 | An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel group, randomized controlled trial to determine the effect of more intensive blood pressure control provided by a fixed low-dose combination | Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT) | ISRCTN76912190 | Version 3 | Phase 3; | grant aided study | Xcene Research Ltd | 15, Ogundana Street, off Alen Avenue, Ikeja Lagos | 16/07/2019 | The George Institute for Global Health | Level 10,King George V Building, 83117 Missenden Rd, Campdown NSW 2050 Ausralia. | 1. Neurology Unit, Dept. of Medicine, University of Ilorin Teaching Hospital (UITH), Ilorin. 2. Dept. of Medicine, Ahmadu Bello University Teaching Hospital (ABUTH), Zaria. 3. Neurology Unit, Dept. of Medicine, Lagos University Teaching Hospital (LUTH), I | Drug | Approved | 26/09/2019 | Recruiting | ?id=2 |
| 3 | 5 | Assessing the Feasibility of Utilizing an Automated Lung Ultrasound (US) Platform among III RV 446/WRAIR 2383 Severe Infectious Disease: Surveillance, Detection, Risks and Consequences in West Africa Participants in Lagos, Nigeria | Ultrasound Study | RV 466 UKT/WRIAR No. 2638, Version 1.4 | Not Applicable | Phase 3; | industry sponsor | U.S Military HIV Research Program Walter Reed Army Institute of Research, Embassy of the United States of Amirica, Abuja, Nigeria | Defense Advanced Research Projects Agency (DARPA), No.7, Clinical Research Center, Usuma Street, Maitama, ABuja. | 29/10/2019 | Defence Advance Research Projects Agency (DARPA), Walter Reed Army Institute of Research | No. 7c, Clinical Research Center, Usuma Street, Maitama, Abuja. | 1. 68, Nigerian Army Reference Hospital, Lagos 2. General Hospital, Ikorodu, Lagos | Medical Device | Approved | 02/01/2020 | Recruiting | ?id=3 |
| 4 | 6 | Stroke Prevention In Young Adults with Sickle Cell Anaemia | SPIYA | Phase 3; | grant aided study | Aminu Kano Teaching Hospital | 2, Zaria Road, Kano | 24/04/2019 | National Institute of Health | 1. Aminu Kano Teaching Hospital | Drug | Approved | 31/12/2019 | on-going | ?id=4 | |||
| 5 | 7 | A Phase IIIB/IV Randomized Open-label Trial Comparing Dolutegravir with Predetermined Nucleosides Versus Recommended Standard of Care ART R regimens in Patients with HIV-1 Infection Failing First Line Therapy | D2EFT: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy | NCT03017872 | Version 2.0 | Phase 3; | grant aided study | The Institute of Human Virology-IHVN | Pent House, Maina Court, Plot 252, Herbert Macauly Way, CDB, Garki Way, Abuja | 20/03/2019 | University of New South Wales | The Kirby Institute, University of New South Wales | 1. University of Abuja Teaching Hospital, Gwagwalada, Area Council, Abuja 2. National Hospital Abuja, 265 Independence Avenue, CBD, Abuja | Drug | Approved | On-going | ?id=5 | |
| 6 | 8 | Assessing Response to neo-adjuvant Taxotere and Trastuzumab in Nigerian women with HER2-positive breast cancer | ARTETTA | CABC123D4567 | 1 | Phase 3; | industry sponsor | Prof. (Mrs) Peace Babalola | Pharmacy Department, University College Hospital Ibadan | 17/07/2019 | University of Chicago, Bilogical Science Division/University of Chicago Medical Center | University of Chicago Center for Global Health (UC CGH), 60637 Chicago, USA | 1. Lagos State University Teaching Hospital, Ikeja, Lagos State 2. Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) Ile Ife 3. Lagos University Teaching Hospital LUTH 4. University College Hospital, Ibadan | Drug | Approved | 15/08/2019 | on-going | ?id=6 |
| 7 | 9 | A phase III, randomised, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering v | WHO Carbetocin RTS Study | A65870 | 1.1 | Phase 3; | grant aided study | Dr Bukola Fawole | Department of Obsterics & Gynaecology , University College Hospital, Ibadan | 03/02/2015 | Department of Reproductive Health & Research, World Health Organization | Avenue Appia 20 1211 Geneva 27 switzerland | 1. Department of Obstetrics & Gynaecology, University College Hospital, Ibadan. | Drug | Approved | 21/04/2015 | Completed | ?id=7 |
| 8 | 10 | Primary Prevention of Stroke in Nigerian Children with Sickle Cell Disease in Sub Saharan Africa II: a partial double blind randomized Phase III clinical trial | SPRING TRIAL | May 23, 2016 | Phase 3; | grant aided tudy | Aminu Kano Teaching Hospital | Zaria road, Kano | 20/09/2016 | Vanderbilt University School of Medicine | Nashville USA | 1. Aminu Kano Teaching Hospital, Kano 2. Murtala Mohammed Specialist Hospital, Kano 3. Barau Dikko Teaching Hospital, Kaduna | Drug | Approved | 09/02/2017 | On going | ?id=8 | |
| 9 | 11 | A multi-country, multi-centre, two arm, parallel, double blind, placebo controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low resource countries to improve newborn out | ACTION-1 Trial | A65913 | 1.10 | Phase 3; | grant aided study | Dr Idowu Ayede | Department of Obstetrics & Gynecology, University College Hospital, Ibadan | 06/09/2017 | World Health Organization | Department of Reproductive Health and Research, Avenue Appia 20 12111 Geneva 27, Switzerland | 1. University College Hospital, Ibadan 2. Mother and Child Hospital, Akure 3. State Specialist Hospital, Akure 4. Nyanya General Hospital, Abuja 5. Kubwa General Hospital, Abuja 6. Lagos state University Teaching Hospital, Ikeja 7. Lagos Island Maternity | Biologics | Approved | 09/01/2018 | On-going | ?id=9 |
| 10 | 12 | A multi-country, multi-centre, two arm, parallel, double blind, placebo- controlled, randomized trial of antenatal corticosteriods for women at risk of imminent birth in the late preterm period in hospitals in low resource countries to improve newborn out | ACTION II Trial | A65916 | 1.5 | Phase 3; | grant aided study | Dr Adejumoke Idowu Ayede | Department of Pediatrics, University College Hospital, Ibadan | 06/09/2017 | Department of Reproductive Health & Research, World Health Organisation | Avenue Appia 20 1211 Geneva 27 Switzerland | 1. University College Hospital, Ibadan 2. Mother & Child Hospital, Akure 3. State Specialist Hospital, Akure 4. Nyanya General Hospital, Abuja 5. Lagos Island Maternity Hospital, Lagos 6. Kubwa General Hospital, Abuja 7. Lagos State University Teaching H | Drug | Approved | 09/01/2018 | ?id=10 |
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
